Genomic Medicine Course in Nafplio
About the program
Key information
- Dates: May 13–15, 2027
- Location: Nafplio (Greece)
- Organized by: Medical School of the National and Kapodistrian University of Athens (NKUA), CHS Greece
- Open to: Students from NKUA Medical School "Precision Medicine" elective (up to 12 participants) and Harvard Medical School (2 participants)
- Application period for NKUA students: November 19, 2026 – December 21, 2026
- Application period for Harvard students: November 19, 2026 – January 4, 2027
- Language: English
- Scientific director: Professor Despina Sanoudou, PhD FACMG (National and Kapodistrian University of Athens/CHS)
- Faculty: Assoc. Professor Athena Bazou (National and Kapodistrian University of Athens/CHS), Professor Aristides Eliopoulos (National and Kapodistrian University of Athens), Assist. Professor Jonathan Picker (Harvard), Dr. Frank C. Schuller (Harvard), Professor Sotirios Tsiodras (National and Kapodistrian University of Athens), Assist. Professor Ioannis Vlachos (Harvard), Professor Despina Sanoudou
- Activity administration: Professor Despina Sanoudou, Dr. Evan Katsarelis (CHS Greece)
- Contact email for CHS Greece: programs-eventsgreece@chs.harvard.edu
Overview
In an era where medicine is increasingly defined by molecular insight and data-driven precision, the Genomic Medicine Course in Nafplio offers a rare opportunity for elite undergraduate medical students to immerse themselves in the rapidly evolving field of genomic medicine and its connections with the unique medical traditions of ancient Greece. This intensive three-day program is organized by the National and Kapodistrian University of Athens (NKUA) Medical School and Harvard University's Center for Hellenic Studies in Greece (CHS Greece) with the participation of faculty members of Harvard Medical School (HMS). It is designed to foster transatlantic academic collaboration while equipping future physicians with the conceptual and analytical tools, as well as the historical knowledge, required to navigate the genomic era. The program will take place from May 13 to 15, 2027, at the CHS Greece facilities in Nafplio.
This program will bring together students from NKUA Medical School and Harvard University. It represents not only an academic milestone but a formative experience for those poised to lead in the domains of precision medicine, global health, and ethical innovation. Distinguished faculty from both Harvard and NKUA will lead the course. While at the CHS Greece facilities in Nafplio, all participants will have access to the Center's unique Digital Library to support their research for course projects and designated research sessions.
The curriculum is structured to deliver a high-density, interdisciplinary experience that integrates clinical genomics, pharmacogenomics, bioinformatics, as well as historical and ethical frameworks. Participants will delve into state-of-the-art domains including emerging trends in advanced genetic testing, the clinical translation of personalized medicine from trial design to therapeutic implementation, and the integration of artificial intelligence in diagnostic workflows, all while critically interrogating the societal, historical, ethical, and philosophical dimensions of genomic data. The program emphasizes translational relevance, bridging bench science with bedside application through case-based learning and interactive discussions.
Set against the backdrop of Nafplio, a city steeped in cultural heritage and intellectual symbolism, the course invites participants to reflect on the enduring values of Hellenic humanism while engaging with the most complex challenges of contemporary science and future clinical practice. The CHS Greece venue, a Harvard global office, provides an ideal environment for scholarly exchange, cultural immersion, and professional networking. Students will not only learn from world-class faculty but also engage in meaningful dialogue across cultures, participate in social events, and experience the rich historical and architectural heritage of Nafplio.
Reflections and insights from the 2026 course
Read the summary of the 2026 Genomic Medicine Course in Nafplio and meet the Harvard participants in the 2026 Genomic Medicine Course.
Eligibility, participation, and application procedure
This program is open exclusively to pre-selected, scholarship-awarded students from NKUA Medical School actively registered for the "Precision Medicine" elective (up to 12 participants) and Harvard Medical School (two participants).
This is a non-fee-based activity, and participants will be given certificates of participation during the closing session of the program.
Application can be submitted:
- from NKUA Medical School students between November 19 and December 21, 2026, and
- from Harvard Medical School students between November 19, 2026, and Monday, January 4, 2027, 11:59 pm (Eastern European Time).
All applicants will receive notification by January 29, 2027. Selected participants will receive acceptance messages via email, along with instructions regarding the confirmation of their participation and the submission of related forms.
The application process utilizes separate portals for NKUA and Harvard students.
Information for Harvard applicants
Prospective Harvard University candidates interested in this program should be Medical School graduate students and must apply online through Harvard CARAT. Prior to the start of the course in Nafplio on May 13, the selected Harvard students will participate in a pre-course immersion, which includes a short three-day visit to the NKUA Medical School campus in Athens from May 10 to 12, 2027. As such, applicants from Harvard should plan to arrive in Greece by May 9 and depart no earlier than May 16.
Information for applicants from NKUA Medical School
Prospective NKUA Medical School applicants interested in this program should be undergraduate students actively registered and attending the Greek or English "Precision Medicine" elective course. They must apply online through the "Precision Medicine" elective eClass website.
Provisions
Participants will be provided with coffee breaks during the daily seminar sessions, a group dinner on the second day of the course, and bus transportation from Athens to Nafplio on the morning of May 13, as well as return bus transportation from Nafplio to Athens on the afternoon of May 15.
NKUA Medical School students will receive double-occupancy accommodation in Nafplio for two nights (May 13 and 14), with breakfast included.
The Harvard students will be awarded a travel scholarship from CHS Greece and NKUA to cover airfare to and from Greece and accommodation expenses in both Athens and Nafplio.
Accessibility
The Center for Hellenic Studies in Greece welcomes individuals with disabilities to participate in its programs and activities. If you would like to request accommodations or have questions about the physical access provided, please email programs-eventsgreece@chs.harvard.edu or call +30 27520 47030, in advance of your participation. Requests for accommodations should be made as far in advance as possible. We will explore each request on a case-by-case basis. However, please note that all services are subject to availability.